173 related articles for article (PubMed ID: 19903243)
41. Lipid rafts mediate amyloid-induced calcium dyshomeostasis and oxidative stress in Alzheimer's disease.
Evangelisti E; Wright D; Zampagni M; Cascella R; Fiorillo C; Bagnoli S; Relini A; Nichino D; Scartabelli T; Nacmias B; Sorbi S; Cecchi C
Curr Alzheimer Res; 2013 Feb; 10(2):143-53. PubMed ID: 22950913
[TBL] [Abstract][Full Text] [Related]
42. The ER stress factor XBP1s prevents amyloid-beta neurotoxicity.
Casas-Tinto S; Zhang Y; Sanchez-Garcia J; Gomez-Velazquez M; Rincon-Limas DE; Fernandez-Funez P
Hum Mol Genet; 2011 Jun; 20(11):2144-60. PubMed ID: 21389082
[TBL] [Abstract][Full Text] [Related]
43. Suppression of InsP3 receptor-mediated Ca2+ signaling alleviates mutant presenilin-linked familial Alzheimer's disease pathogenesis.
Shilling D; Müller M; Takano H; Mak DO; Abel T; Coulter DA; Foskett JK
J Neurosci; 2014 May; 34(20):6910-23. PubMed ID: 24828645
[TBL] [Abstract][Full Text] [Related]
44. High-mobility group box-1 protein and β-amyloid oligomers promote neuronal differentiation of adult hippocampal neural progenitors via receptor for advanced glycation end products/nuclear factor-κB axis: relevance for Alzheimer's disease.
Meneghini V; Bortolotto V; Francese MT; Dellarole A; Carraro L; Terzieva S; Grilli M
J Neurosci; 2013 Apr; 33(14):6047-59. PubMed ID: 23554486
[TBL] [Abstract][Full Text] [Related]
45. Molecular Mechanisms Underlying Neuroprotective Effect of Intranasal Administration of Human Hsp70 in Mouse Model of Alzheimer's Disease.
Evgen'ev MB; Krasnov GS; Nesterova IV; Garbuz DG; Karpov VL; Morozov AV; Snezhkina AV; Samokhin AN; Sergeev A; Kulikov AM; Bobkova NV
J Alzheimers Dis; 2017; 59(4):1415-1426. PubMed ID: 28759972
[TBL] [Abstract][Full Text] [Related]
46. PGE2 EP1 receptor exacerbated neurotoxicity in a mouse model of cerebral ischemia and Alzheimer's disease.
Zhen G; Kim YT; Li RC; Yocum J; Kapoor N; Langer J; Dobrowolski P; Maruyama T; Narumiya S; Doré S
Neurobiol Aging; 2012 Sep; 33(9):2215-9. PubMed ID: 22015313
[TBL] [Abstract][Full Text] [Related]
47. Stabilizing ER Ca2+ channel function as an early preventative strategy for Alzheimer's disease.
Chakroborty S; Briggs C; Miller MB; Goussakov I; Schneider C; Kim J; Wicks J; Richardson JC; Conklin V; Cameransi BG; Stutzmann GE
PLoS One; 2012; 7(12):e52056. PubMed ID: 23284867
[TBL] [Abstract][Full Text] [Related]
48. Presenilin 1 mutation decreases both calcium and contractile responses in cerebral arteries.
Toussay X; Morel JL; Biendon N; Rotureau L; Legeron FP; Boutonnet MC; Cho YH; Macrez N
Neurobiol Aging; 2017 Oct; 58():201-212. PubMed ID: 28753475
[TBL] [Abstract][Full Text] [Related]
49. Morphine protects against intracellular amyloid toxicity by inducing estradiol release and upregulation of Hsp70.
Cui J; Wang Y; Dong Q; Wu S; Xiao X; Hu J; Chai Z; Zhang Y
J Neurosci; 2011 Nov; 31(45):16227-40. PubMed ID: 22072674
[TBL] [Abstract][Full Text] [Related]
50. Alzheimer's Disease Presenilin-1 Mutation Sensitizes Neurons to Impaired Autophagy Flux and Propofol Neurotoxicity: Role of Calcium Dysregulation.
Yang M; Wang Y; Liang G; Xu Z; Chu CT; Wei H
J Alzheimers Dis; 2019; 67(1):137-147. PubMed ID: 30636740
[TBL] [Abstract][Full Text] [Related]
51. CD44 Splice Variants as Potential Players in Alzheimer's Disease Pathology.
Pinner E; Gruper Y; Ben Zimra M; Kristt D; Laudon M; Naor D; Zisapel N
J Alzheimers Dis; 2017; 58(4):1137-1149. PubMed ID: 28550248
[TBL] [Abstract][Full Text] [Related]
52. Presenilin 1 mutation likely contributes to U1 small nuclear RNA dysregulation and Alzheimer's disease-like symptoms.
Cheng Z; Shang Y; Xu X; Dong Z; Zhang Y; Du Z; Lu X; Zhang T
Neurobiol Aging; 2021 Apr; 100():1-10. PubMed ID: 33450722
[TBL] [Abstract][Full Text] [Related]
53. Neurotoxicity of a carboxyl-terminal fragment of the Alzheimer's amyloid precursor protein.
Kim SH; Suh YH
J Neurochem; 1996 Sep; 67(3):1172-82. PubMed ID: 8752124
[TBL] [Abstract][Full Text] [Related]
54. Presenilins regulate calcium homeostasis and presynaptic function via ryanodine receptors in hippocampal neurons.
Wu B; Yamaguchi H; Lai FA; Shen J
Proc Natl Acad Sci U S A; 2013 Sep; 110(37):15091-6. PubMed ID: 23918386
[TBL] [Abstract][Full Text] [Related]
55. Presenilin-1 mutations increase levels of ryanodine receptors and calcium release in PC12 cells and cortical neurons.
Chan SL; Mayne M; Holden CP; Geiger JD; Mattson MP
J Biol Chem; 2000 Jun; 275(24):18195-200. PubMed ID: 10764737
[TBL] [Abstract][Full Text] [Related]
56. Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid beta-peptide.
Guo Q; Furukawa K; Sopher BL; Pham DG; Xie J; Robinson N; Martin GM; Mattson MP
Neuroreport; 1996 Dec; 8(1):379-83. PubMed ID: 9051814
[TBL] [Abstract][Full Text] [Related]
57. Antioxidants prevent amyloid peptide-induced apoptosis and alteration of calcium homeostasis in cultured cortical neurons.
Huang HM; Ou HC; Hsieh SJ
Life Sci; 2000 Mar; 66(19):1879-92. PubMed ID: 10809185
[TBL] [Abstract][Full Text] [Related]
58. Increased expression of miRNA-146a in Alzheimer's disease transgenic mouse models.
Li YY; Cui JG; Hill JM; Bhattacharjee S; Zhao Y; Lukiw WJ
Neurosci Lett; 2011 Jan; 487(1):94-8. PubMed ID: 20934487
[TBL] [Abstract][Full Text] [Related]
59. Hypoxic remodelling of Ca2+ mobilization in type I cortical astrocytes: involvement of ROS and pro-amyloidogenic APP processing.
Smith IF; Boyle JP; Green KN; Pearson HA; Peers C
J Neurochem; 2004 Feb; 88(4):869-77. PubMed ID: 14756807
[TBL] [Abstract][Full Text] [Related]
60. PSEN1 promoter demethylation in hyperhomocysteinemic TgCRND8 mice is the culprit, not the consequence.
Fuso A; Cavallaro RA; Nicolia V; Scarpa S
Curr Alzheimer Res; 2012 Jun; 9(5):527-35. PubMed ID: 22272624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
